Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Develop an Algorithm for Predicting the Unfavorable Course of Sepsis in Children Based on a Comprehensive Assessment of Immunological, Biochemical and Molecular Genetic Markers

NCT05908162 is registered in ClinicalTrials.gov with The Republican Research and Practical Center for Epidemiology and Microbiology as lead sponsor.

NCT NCT05908162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05908162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Develop an Algorithm for Predicting the Unfavorable Course of Sepsis in Children Based on a Comprehensive Assessment of Immunological, Biochemical and Molecular Genetic Markers
Lead sponsor
The Republican Research and Practical Center for Epidemiology and Microbiology
Phase
Observational
Overall status
Completed
Start date
July 1, 2021
Completion date
January 1, 2025
Enrollment
185 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis